middle.news
Percheron Raises $2.2M to Advance HMBD-002 Phase II Trial
8:57am on Thursday 30th of April, 2026 AEST
•
Biotechnology
Read Story
Percheron Raises $2.2M to Advance HMBD-002 Phase II Trial
8:57am on Thursday 30th of April, 2026 AEST
Key Points
Entitlement offer raises $2.2 million
HMBD-002 abstracts accepted at AACR and ASCO
Manufacture of clinical trial drug batch initiated
Phase II trial preparation progressing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Percheron Therapeutics (ASX:PER)
OPEN ARTICLE